4//SEC Filing
ROSENWALD LINDSAY A MD 4
Accession 0001104659-24-079100
CIK 0001429260other
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 8:00 AM ET
Size
5.6 KB
Accession
0001104659-24-079100
Insider Transaction Report
Form 4
ROSENWALD LINDSAY A MD
Director
Transactions
- Purchase
SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
2024-07-09$7.39/sh+5,000$36,971→ 122,500 total
Footnotes (1)
- [F1]Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on July 9, 2024 was $7.25 to $7.48. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0000941841
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 8:00 AM ET
- Size
- 5.6 KB